MMP2 and neoplasm: First, the nanovesicles engineered for PPa and LY co-delivery can specifically accumulate and retain at the tumor site via passive tumor targeting effect and MMP-2-mediated cleavage of PEG corona, thus maximizing their therapeutic benefits while minimizing the side effects.